Celldex News, Celldex Quote, CLDX Quote

Celldex (NQ:CLDX) Delayed: 37.18 -0.59 (1.56%)

Prev. Close

$37.77

Open

$37.87

52 Wk High

$18.62

52 Wk Low

$2.85

Day High

$38.00

Day Low

$37.05

P/E

N/A

EPS

$-1.02

Volume

166,278

Friends, Peers and Foes (?): LHX, EG, CZR, APLS, UNH (more...)

Apr 17, 2024 08:05 AM Celldex (CLDX) Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
Apr 17, 2024 08:01 AM Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
Mar 8, 2024 07:00 AM Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Mar 5, 2024 10:30 AM Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
Mar 5, 2024 10:10 AM Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 1, 2024 04:10 PM Form 8-K Celldex Therapeutics, For: Feb 28
Mar 1, 2024 04:09 PM Form 424B5 Celldex Therapeutics,
Feb 29, 2024 09:15 PM Celldex (CLDX) Announces Pricing of $400 mln Public Offering of Common Stock
Feb 29, 2024 09:14 PM Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock
Feb 28, 2024 04:13 PM Form 424B5 Celldex Therapeutics,

Entities mentioned with CLDX